HELX
HELX
About Franklin Genomic Advancements ETF
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of...
About Franklin Genomic Advancements ETF
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 NTRA | Natera, Inc. | 6.60% | 7.13K | $1.48M |
 GH | Guardant Health, Inc. | 6.57% | 15.72K | $1.48M |
 KRYS | Krystal Biotech, Inc. | 5.42% | 4.42K | $1.22M |
 INSM | Insmed Incorporated | 3.94% | 5.93K | $885.83K |
 UTHR | United Therapeutics Corporation | 3.77% | 1.68K | $846.55K |
 BBIO | BridgeBio Pharma, Inc. | 3.61% | 12.19K | $810.52K |
 ADPT | Adaptive Biotechnologies Corporation | 3.44% | 48.24K | $772.88K |
 LGND | Ligand Pharmaceuticals Incorporated | 3.35% | 3.79K | $752.39K |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.18% | 2.15K | $714.78K |
 VRTX | Vertex Pharmaceuticals Incorporated | 3.17% | 1.44K | $712.95K |
 LLY | Eli Lilly and Company | 2.78% | 593 | $623.83K |
 MEDP | Medpace Holdings, Inc. | 2.67% | 1.33K | $599.49K |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.51% | 722 | $564.37K |
 CTVA | Corteva, Inc. | 2.46% | 6.90K | $551.90K |
 EXAS | Exact Sciences Corporation | 2.42% | 5.27K | $544.71K |
 TEM | Tempus AI, Inc. | 2.19% | 9.22K | $491.02K |
 IONS | Ionis Pharmaceuticals, Inc. | 2.15% | 5.96K | $483.41K |
 BNTX | BioNTech SE | 2.13% | 4.34K | $478.40K |
 NBIX | Neurocrine Biosciences, Inc. | 1.59% | 2.69K | $356.15K |
 WGS | GeneDx Holdings Corp. | 1.47% | 4.13K | $329.44K |
SECTOR HOLDINGS
Healthcare
Basic Materials
TechnologyASSET ALLOCATION BY REGION
United States
South Korea
United Kingdom
Germany
Netherlands
Switzerland
Ireland
SingaporeSECTOR HOLDINGS
Healthcare Basic Materials TechnologyASSET ALLOCATION BY REGION
United States South Korea United Kingdom Germany Netherlands Switzerland Ireland SingaporeHoldings (Top 20)
NTRA
Natera, Inc.
GH
Guardant Health, Inc.
KRYS
Krystal Biotech, Inc.
INSM
Insmed Incorporated
UTHR
United Therapeutics Corporation
BBIO
BridgeBio Pharma, Inc.
ADPT
Adaptive Biotechnologies Corporation
LGND
Ligand Pharmaceuticals Incorporated
ALNY
Alnylam Pharmaceuticals, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
LLY
Eli Lilly and Company
MEDP
Medpace Holdings, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
CTVA
Corteva, Inc.
EXAS
Exact Sciences Corporation
TEM
Tempus AI, Inc.
IONS
Ionis Pharmaceuticals, Inc.
BNTX
BioNTech SE
NBIX
Neurocrine Biosciences, Inc.
WGS
GeneDx Holdings Corp.